Comparer des méthodes

	Échelle d'évaluation de l'observance médicamenteuse (MARS)	Questionnaire sur les croyances relatives aux médicaments (BMQ)
Domaine	Pharmacologie	Pharmacologie
Famille	Process / pipeline	Process / pipeline
Année d'origine	2000	1999
Auteur d'origine	Kathryn Thompson, Jayashri Kulkarni, and Anthony A. Sergejew	Rob Horne, John Weinman, and Michelle Hankins
Type	Self-report	Self-report
Source fondatrice	Thompson, K., Kulkarni, J., & Sergejew, A. A. (2000). Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research, 42(3), 241-247.	Horne, R., Weinman, J., & Hankins, M. (1999). The Beliefs about Medicines Questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology & Health, 14(1), 1-24.
Alias	MARS	BMQ
Apparentées	4	4
Résumé	The Medication Adherence Rating Scale (MARS) is a 10-item self-report measure developed by Thompson, Kulkarni, and Sergejew in 2000 to assess medication adherence behaviors and attitudes in psychiatric populations, particularly antipsychotic medication use. Although originally validated in schizophrenia, it has been successfully applied across diverse medical conditions including hypertension, diabetes, and chronic disease management, providing a quick, sensitive assessment of actual adherence frequency and admission of problematic medication-taking behaviors.	The Beliefs about Medicines Questionnaire (BMQ) is an 18-item self-report measure developed by Horne, Weinman, and Hankins in 1999 to assess patients' cognitive beliefs about necessity of medications and concerns about potential adverse effects. It is widely used in clinical research to predict medication adherence, particularly in chronic disease management, and has demonstrated strong predictive validity across diverse populations and disease contexts.